West Syndrome Market Players:
- Marinus Pharmaceuticals, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- SK Biopharmaceuticals Co., Ltd.
- Alkem Laboratories Ltd.
- Supernus Pharmaceuticals, Inc.
- Eisai Co., Ltd.
- Abbott Laboratories
- Upsher-Smith Laboratories, LLC.
- Pfizer Inc.
- H. Lundbeck A/S
- UCB S.A.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of west syndrome is assessed at USD 501.94 million.
The global west syndrome market size was valued at over USD 479.5 million in 2025 and is expected to expand at a CAGR of around 5.2%, surpassing USD 796.06 million revenue by 2035.
North America’s west syndrome market will secure around 40.8% share by 2035, attributed to increasing number of people with traumatic brain injuries.
Key players in the market include Marinus Pharmaceuticals, Inc., SK Biopharmaceuticals Co., Ltd., Alkem Laboratories Ltd., Supernus Pharmaceuticals, Inc., Eisai Co., Ltd., Abbott Laboratories, Upsher-Smith Laboratories, LLC., Pfizer Inc., H. Lundbeck A/S, UCB S.A.
